Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Most loved Web-based feature: Which Stage Do You Like - 2'Seditious behavior': Trump accuses Democrats who made video reminding the military not to follow illegal orders of a crime — but is it?
- 3Geminid meteor shower 2025 peaks next week. Here's what you need to know about this year's best meteor shower
- 4Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- 5Astounding Treehouses All over the Planet
- The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones
- The Most recent Microsoft Surface Star PC: Ideal for Top of the line Planning and Gaming Needs
- Keep It Cool: Uncovering Famous Fridge Brands for Each Home
- 2024 Watch Gathering: The Best Watches of the Year
- Step by step instructions to Streamline Your Dozing Involvement in a Savvy Bed
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
- Takeaways from AP’s report on potential impacts of Alaska’s proposed Ambler Access Road
- The Manual for Electric Vehicles that will be hot dealers in 2023
